KIR2DL1 and neoplasm: Recently, Gimeno et al. have shown that KIR2DL1+ CD8+ T cells showed a gene expression signature related to efficient tumor immunosurveillance, whereas KIR2DL2/L3+ CD8+ T cells showed transcriptomic profiles related to suppressive anti-tumor responses38.